Literature DB >> 10779421

Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis.

J M Soria1, L Almasy, J C Souto, I Tirado, M Borell, J Mateo, S Slifer, W Stone, J Blangero, J Fontcuberta.   

Abstract

Association studies suggest that the G20210A mutation (G to A substitution at nucleotide position 20210) in the prothrombin gene (PT) is associated with increased plasma prothrombin activity and with increased risk for venous thromboembolism. To test directly for linkage between this PT variant and plasma prothrombin activity we performed a family-based study. The G20210A genotypes and plasma prothrombin activity levels were determined in 435 individuals belonging to 22 extended Spanish families. The sample was composed of 388 homozygous (G/G) normal individuals and 43 heterozygote (G/A) and 4 homozygote (A/A) carriers for the G20210A mutation. The results of variance-component linkage analysis yielded a highly significant lod score of 3.6 (P = 2.4 x 10(-5)) between this mutation and a quantitative trait locus (QTL) that influences prothrombin activity. Importantly, a conditional linkage analysis that simultaneously accounted for association with the G20210A variant completely eliminated the linkage signal, which indicates that this mutation affects the function of the prothrombin gene. Additionally, a bivariate linkage analysis of plasma prothrombin activity and thrombosis significantly improved the linkage signal for prothrombin activity (lod score = 4.7; P = 1.5 x 10(-6)) and provided strong evidence that this QTL has a pleiotropic effect on the risk of thrombosis (lod score = 2.43; P =.0004). These results represent the first direct genetic evidence that a QTL in the PT gene influences prothrombin activity levels and susceptibility to thrombosis and strongly support the conclusion that G20210A is a functional polymorphism. (Blood. 2000;95:2780-2785)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779421

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  A statistical method for identification of polymorphisms that explain a linkage result.

Authors:  Lei Sun; Nancy J Cox; Mary Sara McPeek
Journal:  Am J Hum Genet       Date:  2002-01-08       Impact factor: 11.025

2.  Identifying the susceptibility gene(s) in a set of trait-linked genes using genotype data.

Authors:  Ao Yuan; Guanjie Chen; Yuanxiu Chen; Charles Rotimi; George E Bonney
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

3.  Residual linkage: why do linkage peaks not disappear after an association study?

Authors:  Scott Gordon; Peter M Visscher
Journal:  Hum Genet       Date:  2006-10-27       Impact factor: 4.132

4.  A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.

Authors:  Kevin R Viel; Deepa K Machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan C Souto; Juan M Peralta; Todd Smith; John Blangero; Sandra Porter; Stephen T Warren; Jordi Fontcuberta; Jose M Soria; W Dana Flanders; Laura Almasy; Tom E Howard
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

5.  MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Mario D'Amico; Linda Pasta; Piero Sammarco
Journal:  J Thromb Thrombolysis       Date:  2008-07-10       Impact factor: 2.300

6.  A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease.

Authors:  José Manuel Soria; Laura Almasy; Juan Carlos Souto; Delphine Bacq; Alfonso Buil; Alexandra Faure; Elisabeth Martínez-Marchán; José Mateo; Montserrat Borrell; William Stone; Mark Lathrop; Jordi Fontcuberta; John Blangero
Journal:  Am J Hum Genet       Date:  2002-01-22       Impact factor: 11.025

7.  Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families.

Authors:  Jorge Esparza-Gordillo; José Manuel Soria; Alfonso Buil; Joan Carles Souto; Laura Almasy; John Blangero; Jordi Fontcuberta; Santiago Rodríguez de Córdoba
Journal:  Immunogenetics       Date:  2003-02-22       Impact factor: 2.846

8.  A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.

Authors:  Qing Ling Duan; Borzoo Nikpoor; Marie-Pierre Dube; Giuseppe Molinaro; Inge A Meijer; Patrick Dion; Daniel Rochefort; Judith Saint-Onge; Leah Flury; Nancy J Brown; James V Gainer; Jean L Rouleau; Angelo Agostoni; Massimo Cugno; Pierre Simon; Pierre Clavel; Jacky Potier; Bassem Wehbe; Seddik Benarbia; Julien Marc-Aurele; Jacques Chanard; Tatiana Foroud; Albert Adam; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2005-09-01       Impact factor: 11.025

9.  Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

Authors:  Nilüfer Ertekin-Taner; James Ronald; Hideaki Asahara; Linda Younkin; Maria Hella; Shushant Jain; Eugene Gnida; Samuel Younkin; Daniel Fadale; Yasumasa Ohyagi; Adam Singleton; Leah Scanlin; Mariza de Andrade; Ronald Petersen; Neill Graff-Radford; Michael Hutton; Steven Younkin
Journal:  Hum Mol Genet       Date:  2003-10-14       Impact factor: 6.150

10.  Genetic and environmental factors influencing the human factor H plasma levels.

Authors:  Jorge Esparza-Gordillo; José Manuel Soria; Alfonso Buil; Laura Almasy; John Blangero; Jordi Fontcuberta; Santiago Rodríguez de Córdoba
Journal:  Immunogenetics       Date:  2004-04-30       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.